Advertisement
Don’t stop anti-TNFs, ustekinumab or vedolizumab
Integrating novel treatment with pioneering research
Study affirms XRT’s utility
A quick review of several advances in risk assessment and treatment
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Conditional survival study finds pouch survival improves over time
Immune-mediated factors may be involved
A preview of research findings that could impact your GI practice
More CME: GI endoscopy, medical/surgical options for Crohn’s disease, ulcerative colitis
Build the team and listen to its members, this gastroenterology leader advises
Innovative Cleveland Clinic programs reduce fragmentation of care
Advertisement
Advertisement